Co-Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Co-Diagnostics and other ETFs, options, and stocks.

About CODX

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. 

CEO
Dwight Howard Egan
CEODwight Howard Egan
Employees
115
Employees115
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
2013
Founded2013
Employees
115
Employees115

CODX Key Statistics

Market cap
6.72M
Market cap6.72M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
Dividend yield
Average volume
317.38K
Average volume317.38K
High today
$1.03
High today$1.03
Low today
$0.9057
Low today$0.9057
Open price
$0.955
Open price$0.955
Volume
413.63K
Volume413.63K
52 Week high
$46.50
52 Week high$46.50
52 Week low
$0.9057
52 Week low$0.9057

Stock Snapshot

With a market cap of 6.72M, Co-Diagnostics(CODX) trades at $0.98. The stock has a price-to-earnings ratio of -0.04.

As of 2026-09-20, Co-Diagnostics(CODX) stock has fluctuated between $0.91 and $1.03. The current price stands at $0.98, placing the stock +8.2% above today's low and -4.7% off the high.

Co-Diagnostics(CODX) shares are trading with a volume of 413.63K, against a daily average of 317.38K.

During the past year, Co-Diagnostics(CODX) stock moved between $0.91 at its lowest and $46.50 at its peak.

During the past year, Co-Diagnostics(CODX) stock moved between $0.91 at its lowest and $46.50 at its peak.

CODX News

TipRanks 4d
Co-Diagnostics Highlights PCR Platform and Global Partnerships

The latest announcement is out from Co-Diagnostics ( (CODX) ). On September 16, 2026, Co-Diagnostics, Inc. plans to host an investor and analyst presentation h...

TipRanks 4d
Co-Diagnostics and ReadyGo Diagnostics announce collaboration program

Co-Diagnostics (CODX) and ReadyGo Diagnostics, a UK-based developer of field sample-preparation technology, announced that the companies are collaborating to ev...

TipRanks 5d
Co-Diagnostics to hold a press conference

CEO Dwight Egan to hold a press conference in New York on September 16 at 10:30 am.Webcast Link Published first on TheFly – the ultimate source for real-time,...

People also own

Based on the portfolios of people who own CODX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.